Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3251–3300 of 75356
On March 24, 2025, Briley Brisendine, the Company’s Executive Vice President, General Counsel and Secretary, notified the Company of his intent to resign from the Company.
Cathy McCarthy would not stand for re-election as a Class III director on the Board of Directors of the Company (the “Board”) upon the completion of her current term, which expires at the Company’s 2025 Annual Meeting of Stockholders
On March 28, 2025, Werner Cautreels notified Traws Pharma, Inc. (the Company”) of his decision to retire and resign from his role as Chief Executive Officer of the Company, effective as of the close of business on the day that the Company files its Annual Report on Form 10-K for its 2024 fiscal year
On March 24, 2025, Gerard Waldt notified the Board of Trustees (the “Board”) of T. Rowe Price OHA Select Private Credit Fund (the “Company”) of his resignation as the Company’s Chief Financial Officer
On March 24, 2025, Gerard Waldt notified the Board of Managers (the “Board”) of OHA Senior Private Lending Fund (U), LLC (the “Company”) of his resignation as the Company’s Chief Financial Officer in order to pursue other professional opportunities.
Matthew Winkler resigned from the Board, effective immediately prior to the shareholders meeting to be held in 2025
In connection with the consummation of the Merger, James R. Scapa, Matthew Brown and Stephanie Buckner ceased to serve as the Chief Executive Officer, Chief Financial Officer and Chief Operating Officer, respectively, of the Surviving Corporation.
In connection with the consummation of the Merger, James R. Scapa, Matthew Brown and Stephanie Buckner ceased to serve as the Chief Executive Officer, Chief Financial Officer and Chief Operating Officer, respectively, of the Surviving Corporation.
In connection with the consummation of the Merger, James R. Scapa, Matthew Brown and Stephanie Buckner ceased to serve as the Chief Executive Officer, Chief Financial Officer and Chief Operating Officer, respectively, of the Surviving Corporation.
On March 25, 2025, Isabelle F. Geday notified the board of directors (the “Board”) of Arteris, Inc. (the “Company”) of her decision to resign from the Board, effective as of March 27, 2025.
On March 24, 2025, Mr. Carl E. Vogel, a director elected by holders of the Class A Common Stock of Sphere Entertainment Co. (the “Company”), notified the Company of his intention not to stand for re-election when his term expires at the Company’s upcoming 2025 Annual Meeting of Stockholders anticipated to be held on June 4, 2025 (the “Annual Meeting”).
Pursuant to the Prigge Separation Agreement, effective as of March 31, 2025 (the "Transition Date"), Ms. Prigge will continue to serve at 3 ⁄ 4 full time as the Company’s Executive Vice President, Chief Service Delivery Officer during the period commencing on the Transition Date and ending on June 6, 2025 (such period, the "Transition Period").
On March 27, 2025, David L. Herzog, a director of MetLife, Inc. (the “Company”), notified the Company’s Board of Directors (the “Board”) of his decision to resign from the Board, effective May 1, 2025, and not to stand for re-election at the Company’s 2025 annual meeting of shareholders.
On March 26, 2025, EnerSys separated employment with Joern Tinnemeyer, EnerSys’ Senior Vice President and Chief Technology Officer.
L. Michelle Moore's appointment as a member of the Tennessee Valley Authority Board of Directors ended March 27, 2025, at the direction of the President of the United States.
On March 24, 2025, William W. Stead, M.D. notified HealthStream, Inc. (the “Company”) that he has decided not to stand for re-election to the Company’s Board of Directors (the “Board”) as a Class I director at the Company’s annual meeting of stockholders and to retire from service on the Board effective concurrently with this annual meeting.
On March 27, 2025, Dr. Madaus notified the Board of his intention to resign from the Board and each committee of the Board on which he serves no later than the date of the Company's 2025 annual meeting of stockholders
On March 28, 2025, Dr. Robert Hariri informed BioVie Inc. (the “Company”) of his decision to resign from the Board of Directors of the Company (the “Board”), effective as of such date.
On March 26, 2025, Christopher Merritt, a member of the Board of Directors (the "Board") of DigitalOcean Holdings, Inc. (the "Company"), notified the Company of his intention not to stand for reelection at the Company's 2025 Annual Meeting of Stockholders (the "Annual Meeting").
On March 27, 2025, Julie A. Schertell, a member of the Board of Directors (the “Board”) of Ingersoll Rand Inc. (the “Company”) notified the Board of her intention to resign as a member of the Board and as a member of the Nominating and Corporate Governance Committee and the Sustainability Committee of the Board., effective on March 27, 2025.
On March 24, 2025, Ms. Stacy L. Dillow, Executive Vice President and Chief Human Resources Officer of Fluor Corporation (the “Corporation”), notified the Corporation of her decision to resign from her position, effective April 11, 2025.
Sweetgreen, Inc. (the “Company”) announced that Youngme Moon and Valerie Jarrett will not stand for re-election as directors of the Company at the 2025 annual meeting of stockholders
Sweetgreen, Inc. (the “Company”) announced that Youngme Moon and Valerie Jarrett will not stand for re-election as directors of the Company at the 2025 annual meeting of stockholders
On March 21, 2025, Joseph Mohr resigned from his position as the Board of Directors (the “Board”) of Syntec Optics Holdings, Inc. (the “Company”).
On March 25, 2025, Andrew Munk, Chief Accounting Officer, informed Samsara Inc. (the “Company”) that he plans to retire and will step down from his position as Chief Accounting Officer, effective as of the end of the day on April 8, 2025.
On March 25, 2025, in connection with the Chaintrade transaction, Paul Couture was terminated from his position as Chief Technology Officer of the Company.
John Power, the former President and CEO of the Company resigned as President and CEO
On March 28, 2025, Ms. Ricki Fairley, a director of Xeris Biopharma Holdings, Inc. (the “Company”), notified the Company of her decision to resign from the Board of Directors (the “Board”) of the Company, effective as of March 28, 2025.
On March 28, 2025, Mr. John Schmid informed the Board of his decision to not stand for reelection as a director at the Company’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”).
On March 26, 2025, upon the recommendation of the Governance and Corporate Responsibility Committee of the Board of Directors (the “Board”) of V.F. Corporation (the “Company”), the Board accepted W. Rodney McMullen’s offer of resignation from the Board and reduced the size of the Board to twelve directors, each effective immediately.
On March 21, 2025, Dr. Wendye R. Robbins notified the Board of Directors (the “Board”) of RAPT Therapeutics, Inc. (the “Company”) that she will not stand for election at the Company’s 2025 annual meeting of stockholders (the “Annual Meeting”) and, accordingly, her term on the Board will expire at and as of the Annual Meeting.
On March 27, 2025, Erin L. Polek notified the Board of her decision to resign from the Board and all committees thereof, effective March 31, 2025.
On March 27, 2025, the Company also announced that Pierre Legault, MBA, CPA, and Richard Kender, MBA, would not be standing for re-election at the 2025 Annual Meeting, and that each of Mr. Legault and Mr. Kender would retire from the Board effective immediately following the 2025 Annual Meeting.
Santiago Arroyo, M.D., Ph.D., notified the Board of his resignation as the Company's Chief Development Officer, effective March 24, 2025.
On March 27, 2025, the Company also announced that Pierre Legault, MBA, CPA, and Richard Kender, MBA, would not be standing for re-election at the 2025 Annual Meeting, and that each of Mr. Legault and Mr. Kender would retire from the Board effective immediately following the 2025 Annual Meeting.
On March 25, 2025, Messrs. Sachse and Duskin informed the Board that they will retire from the Board, effective as of April 2, 2025.
On March 25, 2025, Messrs. Sachse and Duskin informed the Board that they will retire from the Board, effective as of April 2, 2025.
On March 24, 2025, Kimberly J. Harris notified the Board of Directors of Ameren Corporation (the "Company") that she was resigning as a director of the Company, effective immediately.
On March 21, 2025, Jessica Buss notified Argo Group International Holdings, Inc. (the “Company”) of her resignation as Chief Executive Officer of the Company, effective immediately
On March 27, 2025, by mutual agreement, Mr. Fricker will no longer serve as interim Chief Financial Officer.
On March 21, 2025, Kurt Schwarz, Chief Accounting Officer and Principal Accounting Officer of Marcus & Millichap, Inc. (the “Company”) notified the Company of his decision to retire and resign from all of his positions with the Company and its subsidiaries, effective March 24, 2025.
On March 21, 2025, James L. Wieser informed the Board of Directors (the “ Board ”) of Finward Bancorp, an Indiana corporation (the “ Bancorp ”), of his decision to retire as a member of the Board of the Bancorp and its wholly-owned Indiana state-chartered commercial bank subsidiary Peoples Bank (“ Peoples Bank ”), effective as of the conclusion of the Bancorp’s 2025 Annual Meeting of Shareholders.
The employment of Thomas Butler as Chief Executive Officer of the Company ended on March 25, 2025 (the “Effective Date”).
On the Effective Date, Mr. Butler resigned as a director and Chairman of the Board
On March 26, 2025, Cathy E. Minehan, a member of the Bright Horizons Family Solutions Inc. (the “Company”) Board of Directors (the “Board”), informed the Board of her intent to retire from the Board, effective June 3, 2025.
On March 25, 2025, Chris Terrill notified the board of directors (the “Board”) of Yelp Inc. (the “Company”) of his decision not to stand for reelection to the Board at the Company’s 2025 annual meeting of stockholders (the “Annual Meeting”).
Ellie Fields notified Calix, Inc. (the “Company”) that she would not be standing for re-election to the Board of Directors (“Board”) of the Company upon the expiration of her term at the Company’s upcoming annual meeting of stockholders scheduled to be held on May 8, 2025.
On March 25, 2025, Maria Eitel, a Class II director of the Board of Directors (the “Board”) of Cloudflare, Inc. (the “Company”) and chair of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), notified the Company of her resignation from the Board, effective as of March 27, 2025.
On March 24, 2025, each of Mr. Alastair Maxwell and Ms. Ann D. Pickard notified the board of directors (the "Board") of Noble Corporation plc (the "Company") that they will not stand for re-election at the Company’s 2025 Annual General Meeting (the "2025 AGM").
On March 24, 2025, each of Mr. Alastair Maxwell and Ms. Ann D. Pickard notified the board of directors (the "Board") of Noble Corporation plc (the "Company") that they will not stand for re-election at the Company’s 2025 Annual General Meeting (the "2025 AGM").
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.